Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Yonsei University
University of Nebraska
University of Nebraska
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Louisiana State University Health Sciences Center Shreveport
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Mayo Clinic
University of Arizona
Ohio State University Comprehensive Cancer Center
Yale University
US Oncology Research
M.D. Anderson Cancer Center
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
Boston Medical Center
Hoag Memorial Hospital Presbyterian
Heidelberg University
Ann & Robert H Lurie Children's Hospital of Chicago
East Valley Hematology and Oncology Medical Group